This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–215 (2010).
David, E., Tramontin, T. & Zemmel, R. Pharmaceutical R&D: the road to positive returns. Nature Rev. Drug Discov. 8, 609–610 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information Box S1
Data sources and analysis methodology (PDF 128 kb)
Rights and permissions
About this article
Cite this article
Berggren, R., Møller, M., Moss, R. et al. Outlook for the next 5 years in drug innovation. Nat Rev Drug Discov 11, 435–436 (2012). https://doi.org/10.1038/nrd3744
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3744
This article is cited by
-
“Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research
Heart Failure Reviews (2022)
-
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
Applied Health Economics and Health Policy (2019)
-
Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
Current Heart Failure Reports (2017)
-
Ethical Hurdles in the Prioritization of Oncology Care
Applied Health Economics and Health Policy (2017)
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine (2016)